Cas:12166-30-2 thulium sulfide manufacturer & supplier

We serve Chemical Name:thulium sulfide CAS:12166-30-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

thulium sulfide

Chemical Name:thulium sulfide
CAS.NO:12166-30-2
Synonyms:EINECS 235-321-7;Dithulium trisulphide;Thulium sulfide
Molecular Formula:S3Tm2
Molecular Weight:434.06300
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:89.48000
Exact Mass:433.78500
LogP:1.94460

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like EINECS 235-321-7 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Thulium sulfide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Thulium sulfide Use and application,Thulium sulfide technical grade,usp/ep/jp grade.


Related News: Alira is one of many in the CRO space to ink deals in recent months. Altasciences acquired preclinical CRO Calvert Laboratories in May, weeks after itself being bought out by Novo Holdings, and a few months after buying early-stage CRO WCCT Global. thulium sulfide manufacturer Alira is one of many in the CRO space to ink deals in recent months. Altasciences acquired preclinical CRO Calvert Laboratories in May, weeks after itself being bought out by Novo Holdings, and a few months after buying early-stage CRO WCCT Global. thulium sulfide supplier In that group, the vaccine slowed brain decline by around 30% in two different clinical and functional tests, Novak said. thulium sulfide vendor Alira is one of many in the CRO space to ink deals in recent months. Altasciences acquired preclinical CRO Calvert Laboratories in May, weeks after itself being bought out by Novo Holdings, and a few months after buying early-stage CRO WCCT Global. thulium sulfide factory Huahai started with the development of characteristic APIs and pharmaceutical intermediates. At the same time, using the international cooperation platform and the opportunity of the expiry of patent protection of major international original research drugs, Huahai has extended the industrial chain to downstream high value-added preparations, and formed intermediates and materials The complete industrial chain of medicine and preparation integration.